The gut-brain axis, the human gut microbiota and their integration in the development of obesity

Frontiers in Physiology

Volumn 9, Issue JUL, 2018, Pages

  Bliss, Edward S ^a   Whiteside, Eliza ^a  

^a UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

Cholecystokinin (CCK); Glucagon like peptide 1 (GLP1); Gut brain axis; Lipopolysaccharide (LPS); Microbiota; Obesity; Peptide YY3 36 (PYY); Short chain fatty acids (SCFA)

Indexed keywords

CHOLECYSTOKININ; ENDOCANNABINOID; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; LIPOPOLYSACCHARIDE; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY [3-36]; SEROTONIN; SHORT CHAIN FATTY ACID;

BEHAVIOR MODIFICATION; BODY WEIGHT GAIN; BRAIN; ENERGY EXPENDITURE; ENTEROENDOCRINE CELL; GASTROINTESTINAL TRACT; HOMEOSTASIS; HORMONE ACTION; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE INNERVATION; NERVE CELL NETWORK; NONHUMAN; OBESITY; PROTEIN FUNCTION; REVIEW; SATIETY; VAGUS NERVE;

EID: 85049867851     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2018.00900     Document Type: Review

References (302)

1. Abbott, C. R., Monteiro, M., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., et al. (2005). The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044, 127-131. doi: 10.1016/j.brainres.2005.03.011
2. Abdel-Salam, O. M. (2014). Capsaicin As a Therapeutic Molecule. Basel: Springer
3. Adam, T. C., and Westerterp-Plantenga, M. S. (2005). Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. Br. J. Nutr. 93, 845-851. doi: 10.1079/BJN20041335
4. Adrian, T. E., Bloom, S. R., Bryant, M. G., Polak, J. M., Heitz, P. H., and Barnes, A. J. (1976). Distribution and release of human pancreatic polypeptide. Gut 17, 940-944. doi: 10.1136/gut.17.12.940
5. Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., and Bloom, S. R. (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89, 1070-1077. doi: 10.1016/0016-5085(85)90211-2
6. Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene, H., Ferrier, L., et al. (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37, 1885-1895. doi: 10.1016/j.psyneuen.2012.03.024
7. Al-Asmakh, M., and Zadjali, F. (2015). Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 25, 1583-1588. doi: 10.4014/jmb.1501.01039
8. Amato, A., Cinci, L., Rotondo, A., Serio, R., Faussone-pellegrini, M. S., Vannucchi, M. G., et al. (2010). Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterol. Motility 22, 664-e203. doi: 10.1111/j.1365-2982.2010.01476.x
9. Anini, Y., Fu-Cheng, X., Cuber, J. C., Kervran, A., Chariot, J., and Roz, é, C. (1999). Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflügers Archiv. 438, 299-306. doi: 10.1007/s004240050913
10. Arendas, K., Qiu, Q., and Gruslin, A. (2008). Obesity in pregnancy: pre-conceptional to postpartum consequences. J. Obstet. Gynaecol. Can. 30, 477-488. doi: 10.1016/S1701-2163(16)32863-8
11. Aronne, L. J., Tonstad, S., Moreno, M., Gantz, I., Erondu, N., Suryawanshi, S., et al. (2010). A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. Int. J. Obes. 34, 919-935. doi: 10.1038/ijo.2010.21
12. Aune, D., Sen, A., Norat, T., Janszky, I., Romundstad, P., Tonstad, S., et al. (2016). Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation 133, 639-649. doi: 10.1161/CIRCULATIONAHA.115.016801
13. Australia, F. (2009). Let's Get Physical: The Economic Contribution of Fitness Centres in Australia. Access Economics
14. Babic, T., Townsend, R. L., Patterson, L. M., Sutton, G. M., Zheng, H., and Berthoud, H.-R. (2009). Phenotype of neurons in the nucleus of the solitary tract that express CCK-induced activation of the ERK signaling pathway. Am. J. Physiol. Regul. Integr. Compar. Physiol. 296, R845-R854. doi: 10.1152/ajpregu.90531.2008
15. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723. doi: 10.1073/pnas.0407076101
16. Baggio, L. L., Huang, Q., Brown, T. J., and Drucker, D. J. (2004). Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127, 546-558. doi: 10.1053/j.gastro.2004.04.063
17. Balasubramaniam, A., Mullins, D. E., Lin, S., Zhai, W., Tao, Z., Dhawan, V. C., et al. (2006). Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. J. Med. Chem. 49, 2661-2665. doi: 10.1021/jm050907d
18. Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., et al. (2003a). Inhibition of food intake in obese subjects by peptide YY3-36. New Engl. J. Med. 349, 941-948. doi: 10.1056/NEJMoa030204
19. Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., et al. (2002). Gut hormone PYY3-36 physiologically inhibits food intake. Nature. 418, 650-654. doi: 10.1038/nature00887
20. Batterham, R. L., Heffron, H., Kapoor, S., Chivers, J. E., Chandarana, K., Herzog, H., et al. (2006). Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 4, 223-233. doi: 10.1016/j.cmet.2006.08.001
21. Batterham, R. L., Le Roux, C. W., Cohen, M. A., Park, A. J., Ellis, S. M., Patterson, M., et al. (2003b). Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 88, 3989-3992. doi: 10.1210/jc.2003-030630
22. Bauer, P. V., Hamr, S. C., and Duca, F. A. (2016). Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota. Cell. Mol. Life Sci. 73, 737-755. doi: 10.1007/s00018-015-2083-z
23. Bedendi, I., Alloatti, G., Marcantoni, A., Malan, D., Catapano, F., Ghé, C., et al. (2003). Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur. J. Pharmacol. 476, 87-95. doi: 10.1016/S0014-2999(03)02083-1
24. Bercik, P., Verdu, E. F., Foster, J. A., Macri, J., Potter, M., Huang, X., et al. (2010). Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 139, 2102-2112.e1. doi: 10.1053/j.gastro.2010.06.063
25. Berntson, G. G., Zipf, W. B., O'Dorisio, T. M., Hoffman, J. A., and Chance, R. E. (1993). Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 14, 497-503. doi: 10.1016/0196-9781(93)90138-7
26. Berthoud, H.-R., Kressel, M., Raybould, H. E., and Neuhuber, W. L. (1995). Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat. Embryol. 191, 203-212. doi: 10.1007/BF00187819
27. Bertrand, P. P., and Bertrand, R. L. (2010). Serotonin release and uptake in the gastrointestinal tract. Autonomic Neurosci. Basic Clin. 153, 47-57. doi: 10.1016/j.autneu.2009.08.002
28. Bertrand, R. L., Senadheera, S., Markus, I., Liu, L., Howitt, L., Chen, H., et al. (2011). A Western diet increases serotonin availability in rat small intestine. Endocrinology 152, 36-47. doi: 10.1210/en.2010-0377
29. Beydoun, M. A., Beydoun, H. A., and Wang, Y. (2008). Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obesity Rev. 9, 204-218. doi: 10.1111/j.1467-789X.2008.00473.x
30. Bianchini, F., Kaaks, R., and Vainio, H. (2002). Overweight, obesity, and cancer risk. Lancet Oncol. 3, 565-574. doi: 10.1016/S1470-2045(02)00849-5
31. Billington, C. J., Briggs, J. E., Link, J. G., and Levine, A. S. (1991). Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo. Am. J. Physiol. Regul. Integr. Comparat. Physiol. 261, R501-R507. doi: 10.1152/ajpregu.1991.261.2.R501
32. Bindels, L. B., Porporato, P., Dewulf, E. M., Verrax, J., Neyrinck, A. M., Martin, J. C., et al. (2012). Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br. J. Cancer. 107, 1337-1344. doi: 10.1038/bjc.2012.409
33. Blackburn, A. M., Bloom, S. R., Long, R. G., Fletcher, D. R., Christofides, N. D., Fitzpatrick, M. L., et al. (1980). Effect of neurotensin on gastric function in man. Lancet 315, 987-989. doi: 10.1016/S0140-6736(80)91434-8
34. Blouet, C., and Schwartz, G. J. (2012). Duodenal lipid sensing activates vagal afferents to regulate non-shivering brown fat thermogenesis in rats. PLoS ONE 7:e51898. doi: 10.1371/journal.pone.0051898
35. Bomhof, M. R., Saha, D. C., Reid, D. T., Paul, H. A., and Reimer, R. A. (2014). Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity 22, 763-771. doi: 10.1002/oby.20632
36. Boyer, J. L., and Bloomer, J. R. (1974). Canalicular bile secretion in man studies utilizing the biliary clearance of [(14)C]mannitol. J. Clin. Investig. 54, 773-781. doi: 10.1172/JCI107817
37. Bremer, A. A., Devaraj, S., Afify, A., and Jialal, I. (2011). Adipose tissue dysregulation in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 96, E1782-E1788. doi: 10.1210/jc.2011-1577
38. Broberger, C., Landry, M., Wong, H., Walsh, J. N., and Hökfelt, T. (1997). Subtypes Y1 and Y2 of the neuropeptide Y Receptor Are Respectively Expressed in Pro-opiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66, 393-408. doi: 10.1159/000127265
39. Brown, L., Poudyal, H., and Panchal, S. K. (2015). Functional foods as potential therapeutic options for metabolic syndrome. Obesity Rev. 16, 914-941. doi: 10.1111/obr.12313
40. Buhmann, H., le Roux, C. W., and Bueter, M. (2014). The gut-brain axis in obesity. Best Pract. Res. Clin. Gastroenterol. 28, 559-571. doi: 10.1016/j.bpg.2014.07.003
41. Bump, R. C., Sugerman, H. J., Fantl, J. A., and McClish, D. K. (1992). Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am. J. Obstet. Gynecol. 167, 392-397; discussion 7-9. doi: 10.1016/S0002-9378(11)91418-5
42. Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani Patrice, D., and Bäckhed, F. (2015). Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metabolism 22, 658-668. doi: 10.1016/j.cmet.2015.07.026
43. Calingasan, N., Ritter, S., Ritter, R., and Brenner, L. (1992). Low-dose near-celiac arterial cholecystokinin suppresses food intake in rats. Am. J. Physiol. Regul. Integr. Comparat. Physiol. 263, R572-R5777. doi: 10.1152/ajpregu.1992.263.3.R572
44. Campos, C. A., Shiina, H., Silvas, M., Page, S., and Ritter, R. C. (2013). Vagal afferent NMDA receptors modulate CCK-induced reduction of food intake through synapsin I phosphorylation in adult male rats. Endocrinology 154, 2613-2625. doi: 10.1210/en.2013-1062
45. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772. doi: 10.2337/db06-1491
46. Cani, P. D., Neyrinck, A. M., Maton, N., and Delzenne, N. M. (2005). Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes. Res. 13, 1000-1007. doi: 10.1038/oby.2005.117
47. Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103. doi: 10.1136/gut.2008.165886
48. Casselbrant, A., Elias, E., Fändriks, L., and Wallenius, V. (2015). Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg. Obes. Relat. Dis. 11, 45-53. doi: 10.1016/j.soard.2014.05.009
49. Castillo, E. J., Delgado-Aros, S., Camilleri, M., Burton, D., Stephens, D., O'Connor-Semmes, R., et al. (2004). Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G363-G369. doi: 10.1152/ajpgi.00074.2004
50. Chen, S. M., Xiong, G. S., and Wu, S. M. (2012). Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J. Digest. Dis. 13, 244-251. doi: 10.1111/j.1751-2980.2012.00587.x
51. Cheng, C. Y., Chu, J. Y., and Chow, B. K. (2011). Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system. Neuropsychopharmacology 36, 459-471. doi: 10.1038/npp.2010.178
52. Cheung, G. W., Kokorovic, A., Lam, C. K., Chari, M., and Lam, T. K. (2009). Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 10, 99-109. doi: 10.1016/j.cmet.2009.07.005
53. Cho, H.-J., Kosari, S., Hunne, B., Callaghan, B., Rivera, L. R., Bravo, D. M., et al. (2015). Differences in hormone localisation patterns of K and L type enteroendocrine cells in the mouse and pig small intestine and colon. Cell Tissue Res. 359, 693-698. doi: 10.1007/s00441-014-2033-3
54. Cho, I., Yamanishi, S., Cox, L., Methe, B. A., Zavadil, J., Li, K., et al. (2012). Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626. doi: 10.1038/nature11400
55. Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., and Astrup, A. (2007). Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370, 1706-1713. doi: 10.1016/S0140-6736(07)61721-8
56. Chu, J. Y. S., Chung, S. C. K., Lam, A. K. M., Tam, S., Chung, S. K., and Chow, B. K. C. (2007). Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption. Mol. Cell. Biol. 27, 2499-2511. doi: 10.1128/MCB.01088-06
57. Clark, J. T., Kalra, P. S., Crowley, W. R., and Kalra, S. P. (1984). Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115, 427-429. doi: 10.1210/endo-115-1-427
58. Cluny, N. L., Chambers, A. P., Vemuri, V. K., Wood, J. T., Eller, L. K., Freni, C., et al. (2011). The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat. Pharmacol. Biochem. Behav. 97, 537-543. doi: 10.1016/j.pbb.2010.10.013
59. Cohen, M. A., Ellis, S. M., Le Roux, C. W., Batterham, R. L., Park, A., Patterson, M., et al. (2003). Oxyntomodulin suppresses appetite and reduces food intake in humans. J. Clin. Endocrinol. Metab. 88, 4696-4701. doi: 10.1210/jc.2003-030421
60. Cone, R., Cowley, M., Butler, A., Fan, W., Marks, D., and Low, M. (2001). The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int. J. Obes. 25:S63. doi: 10.1038/sj.ijo.0801913
61. Cooke, A. R., and Clark, E. D. (1976). Effect of first part of duodenum on gastric emptying in dogs: response to acid, fat, glucose, and neural blockade. Gastroenterology 70, 550-555
62. Costa, M., Brookes, S. J. H., and Hennig, G. W. (2000). Anatomy and physiology of the enteric nervous system. Gut 47(Suppl. 4):iv15-iv19. doi: 10.1136/gut.47.suppl_4.iv15
63. Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., et al. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484. doi: 10.1038/35078085
64. Cox, J. E., McCown, S. M., Bridges, J. M., and Tyler, W. J. (1996). Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions. Am. J. Physiol. Regul. Integr. Compar. Physiol. 270, R319-R325. doi: 10.1152/ajpregu.1996.270.2.R319
65. Craig, A. D. (1996). Chapter 13 An ascending general homeostatic afferent pathway originating in lamina I. Prog. Brain Res. 107, 225-242. doi: 10.1016/S0079-6123(08)61867-1
66. Crane, J. D., Palanivel, R., Mottillo, E. P., Bujak, A. L., Wang, H., Ford, R. J., et al. (2015). Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat. Med. 21, 166-172. doi: 10.1038/nm.3766
67. Dakin, C. L., Small, C. J., Batterham, R. L., Neary, N. M., Cohen, M. A., Patterson, M., et al. (2004). Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145, 2687-2695. doi: 10.1210/en.2003-1338
68. Dakin, C. L., Small, C. J., Park, A. J., Seth, A., Ghatei, M. A., and Bloom, S. R. (2002). Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. Am. J. Physiol. Endocrinol. Metab. 283, E1173-E1177. doi: 10.1152/ajpendo.00233.2002
69. Daly, D. M., Park, S. J., Valinsky, W. C., and Beyak, M. J. (2011). Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J. Physiol. 589, 2857-2870. doi: 10.1113/jphysiol.2010.204594
70. Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., et al. (2002). The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123, 1120-1128. doi: 10.1053/gast.2002.35954
71. Davenport, R. J., and Wright, S. (2014). Treating obesity: is it all in the gut? Drug Discov. Today. 19, 845-858. doi: 10.1016/j.drudis.2013.10.025
72. David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563. doi: 10.1038/nature12820
73. Davis, J. D., and Smith, G. P. (1990). Learning to sham feed: behavioral adjustments to loss of physiological postingestional stimuli. Am. J. Physiol. Regul. Integr. Compar. Physiol. 259, R1228-R1235. doi: 10.1152/ajpregu.1990.259.6.R1228
74. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., et al. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 107, 14691-14696. doi: 10.1073/pnas.1005963107
75. de La Serre, C. B., de Lartigue, G., and Raybould, H. E. (2015). Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol. Behav. 139, 188-194. doi: 10.1016/j.physbeh.2014.10.032
76. de La Serre, C. B., Ellis, C. L., Lee, J., Hartman, A. L., Rutledge, J. C., and Raybould, H. E. (2010). Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointestinal Liver Physiol. 299, G440-G448. doi: 10.1152/ajpgi.00098.2010
77. Deacon, C. F., Johnsen, A. H., and Holst, J. J. (1995). Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J. Clin. Endocrinol. Metab. 80, 952-957
78. Depoortere, I. (2014). Taste receptors of the gut: emerging roles in health and disease. Gut 63, 179-190. doi: 10.1136/gutjnl-2013-305112
79. Dewulf, E. M., Cani, P. D., Claus, S. P., Fuentes, S., Puylaert, P. G., Neyrinck, A. M., et al. (2012). Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121. doi: 10.1136/gutjnl-2012-303304
80. Di Francesco, V., Zamboni, M., Dioli, A., Zoico, E., Mazzali, G., Omizzolo, F., et al. (2005). Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons. J. Gerontol. Series A. 60, 1581-1585. doi: 10.1093/gerona/60.12.1581
81. DiBaise, J. K., and Foxx-Orenstein, A. E. (2013). Role of the gastroenterologist in managing obesity. Expert Rev. Gastroenterol. Hepatol. 7, 439-451. doi: 10.1586/17474124.2013.811061
82. Dicker, A., Zhao, J., Cannon, B., and Nedergaard, J. (1998). Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells. Am. J. Physiol. Regul. Integr. Comparat. Physiol. 275, R1674-R1682. doi: 10.1152/ajpregu.1998.275.5.R1674
83. Dimaline, R., and Varro, A. (2014). Novel roles of gastrin. J. Physiol. 592, 2951-2958. doi: 10.1113/jphysiol.2014.272435
84. Dimitriadis, G., Mitrou, P., Lambadiari, V., Maratou, E., and Raptis, S. A. (2011). Insulin effects in muscle and adipose tissue. Diabetes Res. Clin. Pract. 93, S52-S59. doi: 10.1016/S0168-8227(11)70014-6
85. Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Jacobsen, S. H., Clausen, T. R., et al. (2013). Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int. J. Obes. 37, 1452-1459. doi: 10.1038/ijo.2013.15
86. Dixon, J. B., Lambert, E. A., and Lambert, G. W. (2015). Neuroendocrine adaptations to bariatric surgery. Mol. Cell. Endocrinol. 418, 143-152. doi: 10.1016/j.mce.2015.05.033
87. Dockray, G. J. (2013). Enteroendocrine cell signalling via the vagus nerve. Curr. Opin. Pharmacol. 13, 954-958. doi: 10.1016/j.coph.2013.09.007
88. Druce, M. R., Minnion, J. S., Field, B. C. T., Patel, S. R., Shillito, J. C., Tilby, M., et al. (2009). Investigation of structure-activity relationships of oxyntomodulin (Oxm) using oxm analogs. Endocrinology 150, 1712-1721. doi: 10.1210/en.2008-0828
89. Dryden, S., Pickavance, L., Frankish, H. M., and Williams, G. (1995). Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690, 185-188. doi: 10.1016/0006-8993(95)00628-4
90. Duca, F. A., and Yue, J. T. Y. (2014). Fatty acid sensing in the gut and the hypothalamus: in vivo and in vitro perspectives. Mol. Cell. Endocrinol. 397, 23-33. doi: 10.1016/j.mce.2014.09.022
91. Duca, F. A., Sakar, Y., Lepage, P., Devime, F., Langelier, B., Doré, J., et al. (2014). Replication of obesity and associated signaling pathways through transfer of microbiota from obese prone rat. Diabetes 63, 1624-1636. doi: 10.2337/db13-1526
92. Duca, F. A., Swartz, T. D., Sakar, Y., and Covasa, M. (2012). Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS ONE 7:e39748. doi: 10.1371/journal.pone.0039748
93. Edwards, C. M., Todd, J. F., Mahmoudi, M., Wang, Z., Wang, R. M., Ghatei, M. A., et al. (1999). Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48, 86-93. doi: 10.2337/diabetes.48.1.86
94. Eisner, M. D., Blanc, P. D., Sidney, S., Yelin, E. H., Lathon, P. V., Katz, P. P., et al. (2007). Body composition and functional limitation in COPD. Respir. Res. 8:7. doi: 10.1186/1465-9921-8-7
95. Ejerblad, E., Fored, C. M., Lindblad, P., Fryzek, J., McLaughlin, J. K., and Nyrén, O. (2006). Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 17, 1695-1702. doi: 10.1681/ASN.2005060638
96. Elias, C. F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R. S., Bjorbæk, C., et al. (1999). Leptin differentially regulates, NPYand POMC neurons projecting to the lateral hypothalamic area. Neuron 23, 775-786. doi: 10.1016/S0896-6273(01)80035-0
97. Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., and Marks, V. (1993). Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J. Endocrinol. 138, 159-166. doi: 10.1677/joe.0.1380159
98. El-Salhy, M., Mazzawi, T., Gundersen, D., Hatlebakk, J. G., and Hausken, T. (2013). The role of peptide YY in gastrointestinal diseases and disorders (Review). Int. J. Mol. Med. 31, 275-282. doi: 10.3892/ijmm.2012.1222
99. Enriori, P. J., Evans, A. E., Sinnayah, P., Jobst, E. E., Tonelli-Lemos, L., Billes, S. K., et al. (2007). Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5, 181-194. doi: 10.1016/j.cmet.2007.02.004
100. Eslick, G. D. (2012). Gastrointestinal symptoms and obesity: a meta-analysis. Obesity Rev. 13, 469-479. doi: 10.1111/j.1467-789X.2011.00969.x
101. Esposito, K., Giugliano, F., Di Palo, C., Giugliano, G., Marfella, R., D'Andrea, F., et al. (2004). Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291, 2978-2984. doi: 10.1001/jama.291.24.2978
102. Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., et al. (2014). Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun. 5:5648. doi: 10.1038/ncomms6648
103. Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., and O'Rahilly, S. (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New Engl. J. Med. 348, 1085-1095. doi: 10.1056/NEJMoa022050
104. Fawaz, C. S., Martel, P., Leo, D., and Trudeau, L.-E. (2009). Presynaptic action of neurotensin on dopamine release through inhibition of D2 receptor function. BMC Neurosci. 10:96. doi: 10.1186/1471-2202-10-96
105. Feifel, D., Goldenberg, J., Melendez, G., and Shilling, P. D. (2010). The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature. Neuropharmacology 58, 195-198. doi: 10.1016/j.neuropharm.2009.07.001
106. Finucane, M. M., Sharpton, T. J., Laurent, T. J., and Pollard, K. S. (2014). A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS ONE 9:e84689. doi: 10.1371/journal.pone.0084689
107. Flegal, K. M., Graubard, B. I., Williamson, D. F., and Gail, M. H. (2007). Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298, 2028-2037. doi: 10.1001/jama.298.17.2028
108. Forsythe, P., and Kunze, W. A. (2013). Voices from within: gut microbes and the CNS. Cell. Mol. Life Sci. 70, 55-69. doi: 10.1007/s00018-012-1028-z
109. Fredborg, M., Theil, P. K., Jensen, B. B., and Purup, S. (2012). G protein-coupled receptor120 (GPR120) transcription in intestinal epithelial cells is significantly affected by bacteria belonging to the bacteroides, proteobacteria, and Firmicutes phyla1. J. Anim. Sci. 90(Suppl. 4), 10-12. doi: 10.2527/jas.53792
110. Fu-Cheng, X., Anini, Y., Chariot, J., Castex, N., Galmiche, J.-P., and Rozé, C. (1997). Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflügers Archiv. 433, 571-579. doi: 10.1007/s004240050316
111. Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., et al. (2010). Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss. Links with metabolic and low-grade inflammation markers. Diabetes 59, 3049-3057. doi: 10.2337/db10-0253
112. Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., et al. (2009). Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517. doi: 10.2337/db08-1637
113. Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P., and Dandona, P. (2004). Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110, 1564-1571. doi: 10.1161/01.CIR.0000142055.53122.FA
114. Gibbs, J., Maddison, S., and Rolls, E. T. (1981). Satiety role of the small intestine examined in sham-feeding rhesus monkeys. J. Comp. Physiol. Psychol. 95, 1003-1015. doi: 10.1037/h0077845
115. Gibbs, J., Young, R. C., and Smith, G. P. (1973). Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature. 245, 323-325. doi: 10.1038/245323a0
116. Lu, Y., Hajifathalian, K., Ezzati, M., Woodward, M., Rimm, E. B., et al. (2014). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 383, 970-983. doi: 10.1016/S0140-6736(13)61836-X
117. Gómez, R., Navarro, M., Ferrer, B., Trigo, J. M., Bilbao, A., Del Arco, I., et al. (2002). A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22, 9612-9617. doi: 10.1523/JNEUROSCI.22-21-09612.2002
118. Graaf, C., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., et al. (2016). Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes. Pharmacol. Rev. 68, 954-1013. doi: 10.1124/pr.115.011395
119. Gray, M. A., Greenwell, J. R., and Argent, B. E. (1988). Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J. Membr. Biol. 105, 131-142. doi: 10.1007/BF02009166
120. Grenham, S., Clarke, G., Cryan, J., and Dinan, T. (2011). Brain-gut-microbe communication in health and disease. Front. Physiol. 2:94. doi: 10.3389/fphys.2011.00094
121. Gribble, F. M., and Reimann, F. (2016). Enteroendocrine cells: chemosensors in the intestinal epithelium. Annu. Rev. Physiol. 78, 277-299. doi: 10.1146/annurev-physiol-021115-105439
122. Grima, M., and Dixon, J. (2013). Obesity: recommendations for management in general practice and beyond. Aust. Fam. Physician 42, 532-541. Available online at: https://search.informit.com.au/documentSummary;dn=487012525790449;res=IELHEA
123. Grunddal, K. V., Ratner, C. F., Svendsen, B., Sommer, F., Engelstoft, M. S., Madsen, A. N., et al. (2016). Neurotensin is coexpressed, coreleased, and acts together with GLP-1 and PYY in enteroendocrine control of metabolism. Endocrinology 157, 176-194. doi: 10.1210/en.2015-1600
124. Guerra, S., Sherrill, D. L., Bobadilla, A., Martinez, F. D., and Barbee, R. A. (2002). The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest. 122:1256. doi: 10.1378/chest.122.4.1256
125. Guyenet, S. J., and Schwartz, M. W. (2012). Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J. Clin. Endocrinol. Metab. 97, 745-755. doi: 10.1210/jc.2011-2525
126. Habib, A. M., Richards, P., Cairns, L. S., Rogers, G. J., Bannon, C. A. M., Parker, H. E., et al. (2012). Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153, 3054-3065. doi: 10.1210/en.2011-2170
127. Halford, J. C. G., and Harrold, J. A. (2012). "5-HT2C receptor agonists and the control of appetite," in Appetite Control, ed H.-G. Joost (Berlin, Heidelberg: Springer Berlin), 349-356
128. Halford, J. C. G., Lawton, C. L., and Blundell, J. E. (1997). The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence. Pharmacol. Biochem. Behav. 56, 41-46. doi: 10.1016/S0091-3057(96)00152-9
129. Hall, J. E. (2015). Guyton and Hall Textbook of Medical Physiology. Saint Louis, MO: Elsevier Health Sciences
130. Hamr, S. C., Wang, B., Swartz, T. D., and Duca, F. A. (2015). Does nutrient sensing determine how we "see" food? Curr. Diab. Rep. 15:38. doi: 10.1007/s11892-015-0604-7
131. Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., and Roth, J. D. (2015). Amylin: pharmacology, physiology, and clinical potential. Pharmacol. Rev. 67, 564-600. doi: 10.1124/pr.115.010629
132. Hayes, A. J., Lung, T. W. C., Bauman, A., and Howard, K. (2017). Modelling obesity trends in Australia: unravelling the past and predicting the future. Int. J. Obes. 41, 178-185. doi: 10.1038/ijo.2016.165
133. Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., et al. (2011). Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108, 3047-3052. doi: 10.1073/pnas.1010529108
134. Higham, C. E., Hull, R. L., Lawrie, L., Shennan, K. I. J., Morris, J. F., Birch, N. P., et al. (2000). Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur. J. Biochem. 267, 4998-5004. doi: 10.1046/j.1432-1327.2000.01548.x
135. Hilbert, A., Braehler, E., Haeuser, W., and Zenger, M. (2014). Weight bias internalization, core self-evaluation, and health in overweight and obese persons. Obesity 22, 79-85. doi: 10.1002/oby.20561
136. Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439. doi: 10.1152/physrev.00034.2006
137. Ichimura, A., Hirasawa, A., Poulain-Godefroy, O., Bonnefond, A., Hara, T., Yengo, L., et al. (2012). Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350-354. doi: 10.1038/nature10798
138. Irrazábal, T., Belcheva, A., Girardin Stephen, E., Martin, A., and Philpott Dana, J. (2014). The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell. 54, 309-320. doi: 10.1016/j.molcel.2014.03.039
139. Izzo, A. A., Piscitelli, F., Capasso, R., Aviello, G., Romano, B., Borrelli, F., et al. (2009). Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br. J. Pharmacol. 158, 451-461. doi: 10.1111/j.1476-5381.2009.00183.x
140. Janssens, P. L., Hursel, R., and Westerterp-Plantenga, M. S. (2014). Capsaicin increases sensation of fullness in energy balance, and decreases desire to eat after dinner in negative energy balance. Appetite 77, 46-51. doi: 10.1016/j.appet.2014.02.018
141. Jones, B. J., Tan, T., and Bloom, S. R. (2012). Minireview: glucagon in stress and energy homeostasis. Endocrinology 153, 1049-1054. doi: 10.1210/en.2011-1979
142. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A. R., Malolepszy, J., et al. (2001). Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425. doi: 10.1038/35096564
143. Kalafatakis, K., and Triantafyllou, K. (2011). Contribution of neurotensin in the immune and neuroendocrine modulation of normal and abnormal enteric function. Regul. Pept. 170, 7-17. doi: 10.1016/j.regpep.2011.04.005
144. Kanneganti, T.-D., and Dixit, V. D. (2012). Immunological complications of obesity. Nat. Immunol. 13, 707-712. doi: 10.1038/ni.2343
145. Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A., and Kimura, I. (2015). Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7, 2839-2849. doi: 10.3390/nu7042839
146. Katz, L. M., Young, A., Frank, J. E., Wang, Y., and Park, K. (2004). Neurotensin-induced hypothermia improves neurologic outcome after hypoxic-ischemia*. Crit. Care Med. 32, 806-810. doi: 10.1097/01.CCM.0000114998.00860.FD
147. Kawabata, F., Inoue, N., Masamoto, Y., Matsumura, S., Kimura, W., Kadowaki, M., et al. (2009). Non-pungent capsaicin analogs (capsinoids) increase metabolic rate and enhance thermogenesis via gastrointestinal TRPV1 in mice. Biosci. Biotechnol. Biochem. 73, 2690-2697. doi: 10.1271/bbb.90555
148. Kazumori, H., Ishihara, S., Kawashima, K., Fukuda, R., Chiba, T., and Kinoshita, Y. (2001). Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. FEBS Lett. 489, 208-214. doi: 10.1016/S0014-5793(01)02084-1
149. Kentish, S. J., and Page, A. J. (2015). The role of gastrointestinal vagal afferent fibres in obesity. J. Physiol. 593, 775-786. doi: 10.1113/jphysiol.2014.278226
150. Khandekar, N., Berning, B. A., Sainsbury, A., and Lin, S. (2015). The role of pancreatic polypeptide in the regulation of energy homeostasis. Mol. Cell. Endocrinol. 418, (Part 1), 33-41. doi: 10.1016/j.mce.2015.06.028
151. Kim, G. W., Lin, J. E., Valentino, M. A., Colon-Gonzalez, F., and Waldman, S. A. (2011). Regulation of appetite to treat obesity. Expert Rev. Clin. Pharmacol. 4, 243-259. doi: 10.1586/ecp.11.3
152. Kleinridders, A., Ferris, H. A., Cai, W., and Kahn, C. R. (2014). Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63, 2232-2243. doi: 10.2337/db14-0568
153. Klovaite, J., Benn, M., and Nordestgaard, B. G. (2015). Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. J. Intern. Med. 277, 573-584. doi: 10.1111/joim.12299
154. Koda, S., Date, Y., Murakami, N., Shimbara, T., Hanada, T., Toshinai, K., et al. (2005). The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146, 2369-2375. doi: 10.1210/en.2004-1266
155. Kohno, D., and Yada, T. (2012). Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Neuropeptides 46, 315-319. doi: 10.1016/j.npep.2012.09.004
156. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660. doi: 10.1038/45230
157. Kopin, A. S., Mathes, W. F., McBride, E. W., Nguyen, M., Al-Haider, W., Schmitz, F., et al. (1999). The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J. Clin. Invest. 103, 383-391. doi: 10.1172/JCI4901
158. Korner, J., Bessler, M., Cirilo, L. J., Conwell, I. M., Daud, A., Restuccia, N. L., et al. (2005). Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide, YY, and Insulin. J. Clin. Endocrinol. Metab. 90, 359-365. doi: 10.1210/jc.2004-1076
159. Korner, J., Inabnet, W., Conwell, I. M., Taveras, C., Daud, A., Olivero-Rivera, L., et al. (2006). Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity 14, 1553-1561. doi: 10.1038/oby.2006.179
160. Kuhre, R. E., Wewer Albrechtsen, N. J., Hartmann, B., Deacon, C. F., and Holst, J. J. (2015). Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide. J. Diabetes Complicat. 29, 445-450. doi: 10.1016/j.jdiacomp.2014.12.006
161. Laferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., et al. (2008). Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 93, 2479-2485. doi: 10.1210/jc.2007-2851
162. Lam, D. D., Przydzial, M. J., Ridley, S. H., Yeo, G. S. H., Rochford, J. J., O'Rahilly, S., et al. (2008). Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149, 1323-1328. doi: 10.1210/en.2007-1321
163. Larsen, P. J., Tang-Christensen, M., and Jessop, D. S. (1997). Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat*. Endocrinology 138, 4445-4455. doi: 10.1210/endo.138.10.5270
164. Lassmann, V., Vague, P., Vialettes, B., and Simon, M.-C. (1980). Low plasma levels of pancreatic polypeptide in obesity. Diabetes 29, 428-430. doi: 10.2337/diab.29.6.428
165. le Roux, C. W., Batterham, R. L., Aylwin, S. J. B., Patterson, M., Borg, C. M., Wynne, K. J., et al. (2006). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147, 3-8. doi: 10.1210/en.2005-0972
166. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444:1022. doi: 10.1038/4441022a
167. Li, B., Shao, D., Luo, Y., Wang, P., Liu, C., Zhang, X., et al. (2015). Role of 5-HT3 receptor on food intake in fed and fasted mice. PLoS ONE 10:e0121473. doi: 10.1371/journal.pone.0121473
168. Li, J., Song, J., Zaytseva, Y. Y., Liu, Y., Rychahou, P., Jiang, K., et al. (2016). An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature 533, 411-415. doi: 10.1038/nature17662
169. Li, M., Luo, X., Chen, L., Zhang, J., Hu, J., and Lu, B. (2003). Co-localization of histamine and dopamine-β-hydroxylase in sympathetic ganglion and release of histamine from cardiac sympathetic terminals of guinea-pig. Autonomic Autacoid Pharmacol. 23, 327-333. doi: 10.1111/j.1474-8673.2004.00305.x
170. Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., et al. (2009). GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 106, 1285-1290. doi: 10.1073/pnas.0806720106
171. Lieverse, R. J., Jansen, J. B., Masclee, A. A., and Lamers, C. B. (1995). Satiety effects of a physiological dose of cholecystokinin in humans. Gut 36, 176-179. doi: 10.1136/gut.36.2.176
172. Lin, H. V., Frassetto, A., Kowalik, E. J. Jr, Nawrocki, A. R., Lu, M. M., Kosinski, J. R., et al. (2012). Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7:e35240. doi: 10.1371/journal.pone.0035240
173. Lin, S., Shi, Y.-C., Yulyaningsih, E., Aljanova, A., Zhang, L., Macia, L., et al. (2009). Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. PLoS ONE 4:e8488. doi: 10.1371/journal.pone.0008488
174. Liou, A. P., Paziuk, M., Luevano, J.-M., Machineni, S., Turnbaugh, P. J., and Kaplan, L. M. (2013). Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci. Transl. Med. 5:178ra41. doi: 10.1126/scitranslmed.3005687
175. Liu, Q., Zhang, J., Zerbinatti, C., Zhan, Y., Kolber, B. J., Herz, J., et al. (2011). Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol. 9:e1000575. doi: 10.1371/journal.pbio.1000575
176. Lo, C. C., Sean Davidson, W., Hibbard, S. K., Georgievsky, M., Lee, A., Tso, P., et al. (2014). Intraperitoneal CCK, and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats. Endocrinology 155, 1700-1707. doi: 10.1210/en.2013-1846
177. Löffler, H., Aramaki, J. U. N., and Effendy, I. (2002). The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res. Technol. 8, 19-22. doi: 10.1046/j.0909-752x
178. Ludy, M.-J., Moore, G. E., and Mattes, R. D. (2011). The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans. Chemical Senses. 152, 103-121. doi: 10.1093/chemse/bjr100
179. Mackie, K. (2008). Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol. 20, 10-14. doi: 10.1111/j.1365-2826.2008.01671.x
180. Maida, A., Lovshin, J. A., Baggio, L. L., and Drucker, D. J. (2008). The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances β-cell function but does not inhibit gastric emptying in mice. Endocrinology 149, 5670-5678. doi: 10.1210/en.2008-0336
181. Mayer, E. A., Tillisch, K., and Gupta, A. (2015). Gut/brain axis and the microbiota. J. Clin. Invest. 125, 926-938. doi: 10.1172/JCI76304
182. McAdams DeMarco, M. A., Maynard, J. W., Huizinga, M. M., Baer, A. N., Köttgen, A., Gelber, A. C., et al. (2011). Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res. 63, 1108-1114. doi: 10.1002/acr.20479
183. Meek, C. L., Lewis, H. B., Reimann, F., Gribble, F. M., and Park, A. J. (2016). The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides 77, 28-37. doi: 10.1016/j.peptides.2015.08.013
184. Meier, J. J., Hücking, K., Holst, J. J., Deacon, C. F., Schmiegel, W. H., and Nauck, M. A. (2001). Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes 50, 2497-2504. doi: 10.2337/diabetes.50.11.2497
185. Melanson, E. L. (2017). The effect of exercise on non-exercise physical activity and sedentary behavior in adults. Obesity Rev. 18, 40-49. doi: 10.1111/obr.12507
186. Mentlein, R. (2009). Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP. Best Pract. Res. Clin. Endocrinol. Metab. 23, 443-452. doi: 10.1016/j.beem.2009.03.005
187. Mieczkowska, A., Irwin, N., Flatt, P. R., Chappard, D., and Mabilleau, G. (2013). Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality. Bone 56, 337-342. doi: 10.1016/j.bone.2013.07.003
188. Molenaar, E. A., Numans, M. E., van Ameijden, E. J., and Grobbee, D. E. (2008). Considerable comorbidity in overweight adults: results from the Utrecht Health Project. Netherlands J. Med. 152, 2457-2463
189. Monje, M. (2017). Settling a nervous stomach: the neural regulation of enteric cancer. Cancer Cell 31, 1-2. doi: 10.1016/j.ccell.2016.12.008
190. Mönnikes, H., Lauer, G., Bauer, C., Tebbe, J., Zittel, T. T., and Arnold, R. (1997). Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid. Am. J. Physiol. Regul. Integr. Compar. Physiol. 273, R2059-R2071. doi: 10.1152/ajpregu.1997.273.6.R2059
191. Moran, C. P., and Shanahan, F. (2014). Gut microbiota and obesity: role in aetiology and potential therapeutic target. Best Pract. Res. Clin. Gastroenterol. 28, 585-597. doi: 10.1016/j.bpg.2014.07.005
192. Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., et al. (2010). The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6:392. doi: 10.1038/msb.2010.46
193. Mumphrey, M. B., Patterson, L. M., Zheng, H., and Berthoud, H. R. (2013). Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol. Motility 25, e70-e79. doi: 10.1111/nmo.12034
194. Munkhaugen, J., Lydersen, S., Widerøe, T.-E., and Hallan, S. (2009). Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am. J. Kidney Dis. 54, 638-646. doi: 10.1053/j.ajkd.2009.03.023
195. Münzberg, H., Laque, A., Yu, S., Rezai-Zadeh, K., and Berthoud, H. R. (2015). Appetite and body weight regulation after bariatric surgery. Obesity Rev. 16, 77-90. doi: 10.1111/obr.12258
196. Nakhate, K. T., Kokare, D. M., Singru, P. S., and Subhedar, N. K. (2011). Central regulation of feeding behavior during social isolation of rat: evidence for the role of endogenous CART system. Int. J. Obes. 35, 773-784. doi: 10.1038/ijo.2010.231
197. Neufeld, K. M., Kang, N., Bienenstock, J., and Foster, J. A. (2011). Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motility 23, 255-264. doi: 10.1111/j.1365-2982.2010.01620.x
198. Neyrinck, A. M., Van Hee, V. F., Piront, N., De Backer, F., Toussaint, O., Cani, P. D., et al. (2012). Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr. Diabetes 2:e28. doi: 10.1038/nutd.2011.24
199. Nøhr, M. K., Egerod, K. L., Christiansen, S. H., Gille, A., Offermanns, S., Schwartz, T. W., et al. (2015). Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience 290, 126-137. doi: 10.1016/j.neuroscience.2015.01.040
200. Nørsett, K. G., Lægreid, A., Kusnierczyk, W., Langaas, M., Ylving, S., Fossmark, R., et al. (2008). Changes in gene expression of gastric mucosa during therapeutic acid inhibition. Eur. J. Gastroenterol. Hepatol. 20, 613-623. doi: 10.1097/MEG.0b013e3282f5dc19
201. Nørsett, K. G., Steele, I., Duval, C., Sammut, S. J., Murugesan, S. V. M., Kenny, S., et al. (2011). Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells. Am. J. Physiol. 301, G446-G4453. doi: 10.1152/ajpgi.00527.2010
202. O'Donnell, D. E., Ciavaglia, C. E., and Neder, J. A. (2014). When obesity and chronic obstructive pulmonary disease collide. physiological and clinical consequences. Ann. Am. Thorac. Soc. 11, 635-644. doi: 10.1513/AnnalsATS.201312-438FR
203. Oesch, S., Rüegg, C., Fischer, B., Degen, L., and Beglinger, C. (2006). Effect of gastric distension prior to eating on food intake and feelings of satiety in humans. Physiol. Behav. 87, 903-910. doi: 10.1016/j.physbeh.2006.02.003
204. Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., et al. (2010). GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698. doi: 10.1016/j.cell.2010.07.041
205. Ohlsson, L., Kohan, A. B., Tso, P., and Ahrén, B. (2014). GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat. Regul. Pept. 189, 40-45. doi: 10.1016/j.regpep.2014.02.001
206. Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., et al. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by Agouti-related protein. Science 278, 135-138. doi: 10.1126/science.278.5335.135
207. Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., et al. (2005). A potential decline in life expectancy in the United States in the 21st Century. N. Engl. J. Med. 352, 1138-1145. doi: 10.1056/NEJMsr043743
208. Onakpoya, I. J., Heneghan, C. J., and Aronson, J. K. (2016). Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review. BMC Med. 14:191. doi: 10.1186/s12916-016-0735-y
209. Ono, K., Tsukamoto-Yasui, M., Hara-Kimura, Y., Inoue, N., Nogusa, Y., Okabe, Y., et al. (2011). Intragastric administration of capsiate, a transient receptor potential channel agonist, triggers thermogenic sympathetic responses. J. Appl. Physiol. 110, 789-798. doi: 10.1152/japplphysiol.00128.2010
210. Ortega, F. J., Moreno-Navarrete, J. M., Sabater, M., Ricart, W., Frühbeck, G., and Fernández-Real, J. M. (2011). Circulating glucagon is associated with inflammatory mediators in metabolically compromised subjects. Eur. J. Endocrinol. 165, 639-645. doi: 10.1530/EJE-11-0384
211. Osto, M., Abegg, K., Bueter, M., le Roux, C. W., Cani, P. D., and Lutz, T. A. (2013). Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine. Physiol. Behav. 119, 92-96. doi: 10.1016/j.physbeh.2013.06.008
212. Owen Bryn, M., Ding, X., Morgan Donald, A., Coate Katie, C., Bookout Angie, L., Rahmouni, K., et al. (2014). FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 20, 670-677. doi: 10.1016/j.cmet.2014.07.012
213. Palamiuc, L., Noble, T., Witham, E., Ratanpal, H., Vaughan, M., and Srinivasan, S. (2017). A tachykinin-like neuroendocrine signalling axis couples central serotonin action and nutrient sensing with peripheral lipid metabolism. Nat. Commun. 8:14237. doi: 10.1038/ncomms14237
214. Pan, H., Guo, J., and Su, Z. (2014). Advances in understanding the interrelations between leptin resistance and obesity. Physiol. Behav. 130, 157-169. doi: 10.1016/j.physbeh.2014.04.003
215. Pan, X.-D., and Chen, F.-Q, Wu, T.-X, Tang, H.-G, Zhao, Z.-Y. (2009). Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J. Zhejiang Univ. Sci. B. 10, 258-263. doi: 10.1631/jzus. B0820261
216. Panchal, S. K., Poudyal, H., Waanders, J., and Brown, L. (2012). Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J. Nutr. 142, 690-697. doi: 10.3945/jn.111.153577
217. Panchal, S. K., Ward, L., and Brown, L. (2013). Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur. J. Nutr. 52, 559-568. doi: 10.1007/s00394-012-0358-9
218. Pankov, Y. A. (2016). Adipogenic function and other biologic effects of insulin. Biomed. Khim. 62, 5-13. doi: 10.18097/pbmc20166201005
219. Panula, P., Chazot, P. L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W. L. S., et al. (2015). International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol. Rev. 67, 601-655. doi: 10.1124/pr.114.010249
220. Parker, R. M., and Herzog, H. (1999). Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11, 1431-1448. doi: 10.1046/j.1460-9568.1999.00553.x
221. Parmentier, R., Ohtsu, H., Djebbara-Hannas, Z., Valatx, J.-L., Watanabe, T., and Lin, J.-S. (2002). Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J. Neurosci. 22, 7695-7711. doi: 10.1523/JNEUROSCI.22-17-07695.2002
222. Pestana, I. A., Greenfield, J. M., Walsh, M., Donatucci, C. F., and Erdmann, D. (2009). Management of "buried" penis in adulthood: an overview. Plast. Reconstr. Surg. 124, 1186-1195. doi: 10.1097/PRS.0b013e3181b5a37f
223. Phillips, R. J., and Powley, T. L. (1996). Gastric volume rather than nutrient content inhibits food intake. Am. J. Physiol. Regul. Integr. Compar. Physiol. 271, R766-R769. doi: 10.1152/ajpregu.1996.271.3.R766
224. Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., et al. (2017). Probiotic bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153, 448-459.e8. doi: 10.1053/j.gastro.2017.05.003
225. Pocai, A. (2014). Action and therapeutic potential of oxyntomodulin. Mol. Metab. 3, 241-251. doi: 10.1016/j.molmet.2013.12.001
226. Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., et al. (2009). Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes 58, 2258-2266. doi: 10.2337/db09-0278
227. Polednak, A. P. (2008). Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect. Prev. 32, 190-199. doi: 10.1016/j.cdp.2008.08.004
228. Powell, B. M. (1976). Participation of H1 and H2 histamine receptors in physiological vasodilator responses. Am. J. Physiol. 231, 1002-1009. doi: 10.1152/ajplegacy.1976.231.4.1002
229. Prechtl, J. C., and Powley, T. L. (1990). The fiber composition of the abdominal vagus of the rat. Anat. Embryol. 181, 101-115. doi: 10.1007/BF00198950
230. Psichas, A., Reimann, F., and Gribble, F. M. (2015). Gut chemosensing mechanisms. J. Clin. Invest. 125, 908-917. doi: 10.1172/JCI76309
231. Puente, N., Cui, Y., Lassalle, O., Lafourcade, M., Georges, F., Venance, L., et al. (2011). Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci. 14, 1542-1547. doi: 10.1038/nn.2974
232. Pyarokhil, A. H., Ishihara, M., Sasaki, M., and Kitamura, N. (2012). Immunohistochemical study on the ontogenetic development of the regional distribution of peptide YY, pancreatic polypeptide, and glucagon-like peptide 1 endocrine cells in bovine gastrointestinal tract. Regul. Peptides 175, 15-20. doi: 10.1016/j.regpep.2011.12.004
233. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65. doi: 10.1038/nature08821
234. Rahat-Rozenbloom, S., Fernandes, J., Gloor, G. B., and Wolever, T. M. S. (2014). Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int. J. Obes. 38, 1525-1531. doi: 10.1038/ijo.2014.46
235. Rasmussen, B. A., Breen, D. M., Luo, P., Cheung, G. W. C., Yang, C. S., Sun, B., et al. (2012). Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. Gastroenterology 142, 834.e3-843.e3. doi: 10.1053/j.gastro.2011.12.053
236. Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., et al. (2004). Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabetic Medicine 21, 1204-1212. doi: 10.1111/j.1464-5491.2004.01319.x
237. Ravinet Trillou, C., Delgorge, C., Menet, C., Arnone, M., and Soubrie, P. (2004). CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 28, 640-648. doi: 10.1038/sj.ijo.0802583
238. Reidelberger, R. D., Kalogeris, T. J., Leung, P. M., and Mendel, V. E. (1983). Postgastric satiety in the sham-feeding rat. Am. J. Physiol. Regul. Integr. Comparat. Physiol. 244, R872-R881. doi: 10.1152/ajpregu.1983.244.6.R872
239. Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., et al. (2014). Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes 63, 1224-1233. doi: 10.2337/db13-1440
240. Ritter, R. C. (2011). A tale of two endings: modulation of satiation by NMDA receptors on or near central and peripheral vagal afferent terminals. Physiol. Behav. 105, 94-99. doi: 10.1016/j.physbeh.2011.02.042
241. Rowland, K. J., Trivedi, S., Lee, D., Wan, K., Kulkarni, R. N., Holzenberger, M., et al. (2011). Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion. Gastroenterology 141, 2166-2175.e7. doi: 10.1053/j.gastro.2011.09.014
242. Rüttimann, E. B., Arnold, M., Hillebrand, J. J., Geary, N., and Langhans, W. (2009). Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150, 1174-1181. doi: 10.1210/en.2008-1221
243. Sakata, I., and Sakai, T. (2010). Ghrelin cells in the gastrointestinal tract. Int. J. Pept. 2010:945056. doi: 10.1155/2010/945056
244. Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., et al. (2014). Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br. J. Nutr. 111, 1507-1519. doi: 10.1017/S0007114513003875
245. Sanchez, M., Darimont, C., Panahi, S., Drapeau, V., Marette, A., Taylor, V., et al. (2017). Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Nutrients 9:284. doi: 10.3390/nu9030284
246. Sánchez-Villegas, A., Ruíz-Canela, M., Gea, A., Lahortiga, F., and Martínez-González, M. A. (2016). The association between the mediterranean lifestyle and depression. Clin. Psychol. Sci. 4, 1085-1093. doi: 10.1177/2167702616638651
247. Santo, M. A., Riccioppo, D., Pajecki, D., Kawamoto, F., de Cleva, R., Antonangelo, L., et al. (2016). Weight regain after gastric bypass: influence of gut hormones. Obes. Surg. 26, 919-925. doi: 10.1007/s11695-015-1908-z
248. Savastano, D. M., Hayes, M. R., and Covasa, M. (2007). Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain. Am. J. Physiol. Regul. Integr. Compar. Physiol. 292, R1063-R1070. doi: 10.1152/ajpregu.00699.2006
249. Sayegh, A. I., Covasa, M., and Ritter, R. C. (2004). Intestinal infusions of oleate and glucose activate distinct enteric neurons in the rat. Autonomic Neurosci. 115, 54-63. doi: 10.1016/j.autneu.2004.08.006
250. Schéle, E., Grahnemo, L., Anesten, F., Hallén, A., Bäckhed, F., and Jansson, J.-O. (2013). The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology 154, 3643-3651. doi: 10.1210/en.2012-2151
251. Schéle, E., Grahnemo, L., Anesten, F., Hallén, A., Bäckhed, F., and Jansson, J.-O. (2016). Regulation of body fat mass by the gut microbiota: possible mediation by the brain. Peptides 77, 54-59. doi: 10.1016/j.peptides.2015.03.027
252. Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., and Baskin, D. G. (2000). Central nervous system control of food intake. Nature 404, 661-671. doi: 10.1038/35007534
253. Schwartz, T. W., Holst, J. J., Fahrenkrug, J., Jensen, S. L., Nielsen, O. V., Rehfeld, J. F., et al. (1978). Vagal, cholinergic regulation of pancreatic polypeptide secretion. J. Clin. Invest. 61, 781-789. doi: 10.1172/JCI108992
254. Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., et al. (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195. doi: 10.1038/oby.2009.167
255. Seeley, R. J., Grill, H. J., and Kaplan, J. M. (1994). Neurological dissociation of gastrointestinal and metabolic contributions to meal size control. Behav. Neurosci. 108, 347-352. doi: 10.1037/0735-7044.108.2.347
256. Sender, R., Fuchs, S., and Milo, R. (2016a). Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164, 337-340. doi: 10.1016/j.cell.2016.01.013
257. Sender, R., Fuchs, S., and Milo, R. (2016b). Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14:e1002533. doi: 10.1371/journal.pbio.1002533
258. Shak, J. R., Roper, J., Perez-Perez, G. I., Tseng, C.H., Francois, F., Gamagaris, Z., et al. (2008). The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes. Surg. 18, 1089-1096. doi: 10.1007/s11695-008-9454-6
259. Sheridan, P. A., Paich, H. A., Handy, J., Karlsson, E. A., Hudgens, M. G., Sammon, A. B., et al. (2012). Obesity is associated with impaired immune response to influenza vaccination in humans. Int. J. Obes. 36, 1072-1077. doi: 10.1038/ijo.2011.208
260. Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., et al. (2010). Multicenter, placebo-controlled trial of lorcaserin for weight management. New Engl. J. Med. 363, 245-256. doi: 10.1056/NEJMoa0909809
261. Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J., and Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145, 946-953. doi: 10.1053/j.gastro.2013.08.058
262. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A., and Colzato, L. S. (2015). A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun. 48, 258-264. doi: 10.1016/j.bbi.2015.04.003
263. Stein, P. D., Matta, F., and Goldman, J. (2011). Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox. Thromb. Res. 128, 518-523. doi: 10.1016/j.thromres.2011.10.019
264. Steuten, L. M., Creutzberg, E. C., Vrijhoef, H. J., and Wouters, E. F. (2006). COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Primary Care Respir. J. 15, 84-91. doi: 10.1016/j.pcrj.2005.09.001
265. Stiedl, O., Pappa, E., Konradsson-Geuken, Å., and ögren, S. O. (2015). The role of the serotonin receptor subtypes 5-HT(1A) and 5-HT(7) and its interaction in emotional learning and memory. Front. Pharmacol. 6:162. doi: 10.3389/fphar.2015.00162
266. Stinton, L. M., and Shaffer, E. A. (2012). Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 6, 172-187. doi: 10.5009/gnl.2012.6.2.172
267. Stock, S., Leichner, P., Wong, A. C. K., Ghatei, M. A., Kieffer, T. J., Bloom, S. R., et al. (2005). Ghrelin, Peptide, YY glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J. Clin. Endocrinol. Metab. 90, 2161-2168. doi: 10.1210/jc.2004-1251
268. Suzuki, K., Jayasena, C. N., and Bloom, S. R. (2012). Obesity and appetite control. Exp. Diabetes Res. 2012:824305. doi: 10.1155/2012/824305
269. Svendsen, B., Pedersen, J., Albrechtsen, N. J. W., Hartmann, B., Toräng, S., Rehfeld, J. F., et al. (2015). An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology 156, 847-857. doi: 10.1210/en.2014-1710
270. Swarbrick, M. M., Stanhope, K. L., Austrheim-Smith, I. T., Van Loan, M. D., Ali, M. R., Wolfe, B. M., et al. (2008). Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 51, 1901-1911. doi: 10.1007/s00125-008-1118-5
271. Swartz, T. D., Duca, F., De Wouters, T., Sakar, Y., and Covasa, M. (2012). Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. Br. J. Nutr. 107, 621-630. doi: 10.1017/S0007114511003412
272. Talsania, T., Anini, Y., Siu, S., Drucker, D. J., and Brubaker, P. L. (2005). Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice. Endocrinology 146, 3748-3756. doi: 10.1210/en.2005-0473
273. Tanida, M., Yamano, T., Maeda, K., Okumura, N., Fukushima, Y., and Nagai, K. (2005). Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Neurosci. Lett. 389, 109-114. doi: 10.1016/j.neulet.2005.07.036
274. Tims, S., Derom, C., Jonkers, D. M., Vlietinck, R., Saris, W. H., Kleerebezem, M., et al. (2013). Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J. 7, 707-717. doi: 10.1038/ismej.2012.146
275. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., et al. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-Protein-coupled receptor FFAR2. Diabetes 61, 364-371. doi: 10.2337/db11-1019
276. Tolhurst, P., Lindberg, R., Calder, R., and de Courten, M. (2016). Australia's Health Tracker 2016. Melbourne: The Australian Health Policy
277. Tukker, A., Visscher, T. L. S., and Picavet, H. S. J. (2009). Overweight and health problems of the lower extremities: osteoarthritis, pain and disability. Public Health Nutr. 12, 359-368. doi: 10.1017/S1368980008002103
278. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature 457, 480-484. doi: 10.1038/nature07540
279. Valenzuela, J. E., Walsh, J. H., and Isenberg, J. I. (1976). Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man. Gastroenterology 71, 409-411
280. van der Kooy, D. (1984). Area postrema: site where cholecystokinin acts to decrease food intake. Brain Res. 295, 345-347. doi: 10.1016/0006-8993(84)90982-X
281. Vaure, C., and Liu, Y. (2014). A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front. Immunol. 5:316. doi: 10.3389/fimmu.2014.00316
282. Villanueva-Peñacarrillo, M. L., Márquez, L., González, N., Díaz-Miguel, M., and Valverde, I. (2001). Effect of GLP-1 on lipid metabolism in human adipocytes. Horm. Metab. Res. 33, 73-77. doi: 10.1055/s-2001-12428
283. Vilsbøll, T., Agersø, H., Krarup, T., and Holst, J. J. (2003). Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J. Clin. Endocrinol. Metab. 88, 220-224. doi: 10.1210/jc.2002-021053
284. Wang, H.-X., and Wang, Y.-P. (2016). Gut microbiota-brain axis. Chin. Med. J. 129, 2373-2380. doi: 10.4103/0366-6999.190667
285. Wang, J., Barbuskaite, D., Tozzi, M., Giannuzzo, A., Sørensen, C. E., and Novak, I. (2015). Proton pump inhibitors inhibit pancreatic secretion: role of gastric and non-gastric H+/K+-ATPases. PLoS ONE 10:e0126432. doi: 10.1371/journal.pone.0126432
286. Wang, P., Yan, Z., Zhong, J., Chen, J., Ni, Y., Li, L., et al. (2012). Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes 61, 2155-2165. doi: 10.2337/db11-1503
287. Wilson, P. F., D'Agostino, R. B., Sullivan, L., Parise, H., and Kannel, W. B. (2002). Overweight and obesity as determinants of cardiovascular risk: the framingham experience. Arch. Intern. Med. 162, 1867-1872. doi: 10.1001/archinte.162.16.1867
288. Wostmann, B. S., Larkin, C., Moriarty, A., and Bruckner-Kardoss, E. (1983). Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 33, 46-50
289. Writing Group, M., Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., et al. (2014). Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129, e28-e292. doi: 10.1161/01.cir.0000441139.02102.80
290. Wynne, K., Park, A. J., Small, C. J., Meeran, K., Ghatei, M. A., Frost, G. S., et al. (2006). Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int. J. Obes. 30, 1729-1736. doi: 10.1038/sj.ijo.0803344
291. Wynne, K., Park, A. J., Small, C. J., Patterson, M., Ellis, S. M., Murphy, K. G., et al. (2005). Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects. A double-blind, randomized, controlled trial. Diabetes 54, 2390-2395. doi: 10.2337/diabetes.54.8.2390
292. Yamato, E., Ikegami, H., Takekawa, K., Fujisawa, T., Nakagawa, Y., Hamada, Y., et al. (1997). Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1). Horm. Metab. Res. 29, 56-59. doi: 10.1055/s-2007-978985
293. Yang, Y.-K., Chen, M., Clements, R. H., Abrams, G. A., Aprahamian, C. J., and Harmon, C. M. (2008). Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cell. Physiol. Biochem. 22, 531-538. doi: 10.1159/000185527
294. Yavuz, Y., Kumral, Z. N. Ö., Memi, G., çevik, ö. D., Yegen, C., and Yegen, B. ç. (2017). Serum leptin, obestatin, and ghrelin levels and gastric emptying rates of liquid and solid meals in non-obese rats with roux-en-Y bypass surgery or prosthesis placement: implications for the role of vagal afferents. Obes. Surg. 27, 1037-1046. doi: 10.1007/s11695-016-2420-9
295. Yosipovitch, G., DeVore, A., and Dawn, A. (2007). Obesity and the skin: skin physiology and skin manifestations of obesity. J. Am. Acad. Dermatol. 56, 901-916. doi: 10.1016/j.jaad.2006.12.004
296. Yosipovitch, G., Sackett-Lundeen, L., Goon, A., Yiong Huak, C., Leok Goh, C., and Haus, E. (2004). Circadian and ultradian (12 h) variations of skin blood flow and barrier function in non-irritated and irritated skin-effect of topical corticosteroids. J. Investig. Dermatol. 122, 824-829. doi: 10.1111/j.0022-202X.2004.22313.x
297. Young, R. L., Sutherland, K., Pezos, N., Brierley, S. M., Horowitz, M., Rayner, C. K., et al. (2009). Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut 58, 337-346. doi: 10.1136/gut.2008.148932
298. Yuan, X., Yao, P. Y., Jiang, J., Zhang, Y., Su, Z., Yao, W., et al. (2017). MST4 phosphorylates ACAP4 to orchestrate apical membrane remodeling during gastric acid secretion. J. Biol. Chem. 292, 16174-16187. doi: 10.1074/jbc. M117.808212
299. Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. (2009). Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U.S.A. 106, 2365-2370. doi: 10.1073/pnas.0812600106
300. Zhang, J., and Ritter, R. C. (2012). Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms. Am. J. Physiol. Regul. Integr. Comparat. Physiol. 302, R264-R273. doi: 10.1152/ajpregu.00114.2011
301. Zittel, T. T., De Giorgio, R., Sternini, C., and Raybould, H. E. (1994). Fos protein expression in the nucleus of the solitary tract in response to intestinal nutrients in awake rats. Brain Res. 663, 266-270. doi: 10.1016/0006-8993(94)91272-6
302. Zuo, D. C., Choi, S., Shahi, P. K., Kim, M. Y., Park, C. G., Kim, Y. D., et al. (2013). Inhibition of pacemaker activity in interstitial cells of Cajal by LPS via NF-κB and MAP kinase. World J. Gastroenterol. 19, 1210-1218. doi: 10.3748/wjg.v19.i8.1210